Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Progress and/or gov funding.
I tend to agree with you regarding the reverse split. If the company delivers on the science a reverse might not be necessary.
The R/S would be in conjunction with a NASDAQ listing. There is a $4 minimum bid requirement. The RS would be done simultaenously with a capital raise and listing. GOVX would be a Nasdaq biotech with capital and super tight float. Very positive situation.
David Dodd, President and CEO of GeoVax, stated: “This financing will allow us to continue our work on various projects, including a COVID-19 vaccine, while we prepare for a public offering of our securities to accelerate the advancement of our product pipeline.”
https://www.otcdynamics.com/govx-geovax-announces-closing-of-1-million-private-placement/?utm_campaign=twitter&utm_medium=twitter&utm_source=twitter
You can. Short it.
GOVX plan is a nasdaq listing and a capital raise. Very positive developments if they succeeded. We would have a nasdaq stock with institutional support. Likely analyst coverage. Plenty of capital to move products through testing and into the market. Company also secured a bridge loan to get to the raise. Company now has working capital. Bridge loan very favorable. Only 5% interest. It is convertible after 6 months but the conversion price of $0.50 is above the current market price. It's also callable so might not result in any dilution. This is a real plan to build a legit nasdaq biotech. Current market cap only $5 million. Great risk reward situation.
Not always bad. If done for right reason at right time it can work.
VXRT previously did a split for nasdaq listing. Look at their chart.
Authorized to issue up to 5 million total. Restricted.
8k filed - Stock compensation plan. I have been waiting for this. Positive development. Nothing was going to happen until insiders got their shares. They are now incentivized. My guess is some sort of transaction is in the works. Another piece to the puzzle.
If I was a big pharma or biotech CEO I would buy this company for $10 million in equity, put out a press release announcing a covid vaccine acquisition and watch my market cap go up $50 million in a day. Total cost would be $100 for the press release because the equity would pay for itself.
It's currently a blank canvass. The set up looks great to me. At the very least you have a clean shell with some technology assets on sale for $5 million. You just don't understand what you are looking at. So many possibilities. Funding, capital raise, reverse merger, acquisition target...???
This stock is ready to go. It really is. Any type of funding or positive news it's go to gap and keep on going. It was beaten down and flushed out. Sellers are gone. Now we need a catalyst to get it moving. If they come through the move is going to be insane.
Covid Vaccine Blog
https://covidinvestor.blogspot.com/?m=1
Here is their twitter.
The end of a great week for the market and a poor one for the COVID VACCINE STOCKS. Sorrento (SRNE) the top stock and Nano Viricides (NNVC) and IBIO the laggards.https://t.co/s2e5iEvdaG
— COVID VACCINE INVESTOR (@IanGray44757496) June 5, 2020
GeoVax to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research
https://www.newmediawire.com/news/geovax-to-present-covid-19-vaccine-program-at-national-foundation-for-infectious-diseases-annual-conference-on-vaccinology-research-5053359
100% correct. Some funds have restrictions against investing in pink sheet stocks. An uplist to the OTC increases the pool of potential investors. This includes private placements.
Merck went up $5 billion on vaccine news this week.
Merck is up $5 billion today on vaccine news but ok.
They need to really do it. Hire an investment banker and put out a press release saying they are exploring strategic options. First the insiders need to award themselves some stock. That's an incentive that is missing. Even easier and quicker would be to convert the deferred salaries to equity at current market price. Cleans up the balance sheet, shows confidence in the stock and incentivizes management to get a deal done.
GeoVax needs to put themselves on the auction block. Merck just added $7 billion to their market cap with a couple of vaccine acquisitions. Meanwhile GOVX is on sale for $6 million. This is crazy.
Billions that have been allocated by law for a vaccine have yet to be dispursed. Funding is still available.
That was my favorite part too. If GOVX gets funding and actually makes progress on a vaccine this stock has so far to run. It's going to be wild.
Article on public companies working on a vaccine.
https://www.fool.com/investing/2020/05/17/is-buying-a-basket-loaded-with-every-coronavirus-v.aspx
Of course they would have been done without covid. But covid happened. There is interest in the stock which allowed preferred holders to convert. No more overhang. Only 14 million shares out. BILLIONS have been allocated for a vaccine that have yet to be dispersed. GOVX has a tremendous second chance opportunity.
I like this post.
I don't think so. Stock price and volume usually tell the story early.
Today noon, Trump press conference in the Rose Garden regarding vaccine development.
https://factba.se/topic/calendar
The White House is expected to announce a new partnership between the U.S. military and the private sector to develop a coronavirus vaccine. An official announcement is expected Friday afternoon in the White House Rose Garden.
— FOX News Radio (@foxnewsradio) May 15, 2020
Listen & Subscribe:https://t.co/XsFphVcG0M
Me too. A big press conference with all the CEOs. Trump will call Dodd up to speak in the rose garden and the sad trombone will have an aneurysm.
They ran it up into the close. Too funny.
Are you saying GOVX just became compliant with reporting requirements? Company should be able to move off the pink sheets up to OTCQB.
That is weird. If they converted yesterday they would get stock below .20 and sell today for .50. That's a nice return. Maybe they are waiting for the big move.
I stand corrected. I wish they would convert and just get out of the way.
The 10Q numbers were as of 3/31/20. I suspect Sabby converted some in the last few days. Sabby is not an investor. Essentially they are a lender. They might hold some if they think the stock is going higher but typically they convert at a discount and dump. Move on to the next deal. That's their business model. Not investing.
Churning through some overhang here in the low .50s. Looks like a combination of Sabby and some traders who got caught in Mondays spike. I really like the way it's been trading. Eventually the overhang will be done and then it's blue sky.
Press release on Q1 results.
https://finance.yahoo.com/news/geovax-reports-2020-first-quarter-130010076.html
GeoVax Reports 2020 First Quarter Financial Results and Provides Corporate Update
There are still billions allocated but yet to be dispursed.
Since you asked.
There are still BILLIONS in gov funding that have been allocated by law for a vaccine but not dispursed yet. Plenty of money to come. GOVX submitted an application for $20 million in February. They had a follow up meeting in late March where government requested a white paper. If they are requesting a white paper they are obviously seriously considering funding GOVX. Funding is imminent. Imo.
I read through the 10Q real quick and didn't see any surprises. Nothing new unless I missed it. Seem to be ok on cash for now with the ppp loan. Excellent terms. Only $300k preferred left but that was March 31. Probably lower now. There is an additional $100k preferred at much much higher conversion price. Ignore it. I'll check the 10q closer later tonight. First glance it's benign.
You are correct. Except the preferred is almost cleaned up. I guess only $200k left.
Should be done soon. Will be about 15 million shares outstanding when they are done. Clean capital structure and low float going forward.
**Funding requests (public and private) are currently submitted and a successful outcome is expected.**
You are correct. Being included in the program is a grand slam. Receiving funding would be a home run. Our international friend might not get the baseball analogy.